American Pharmaceutical Partners have announced that its cancer-fighting drug Abraxane has demonstrated greater tumour reduction and fewer side effects when compared to a solvent-dissolved equivalent....
http://www.azonano.com/article.aspx?ArticleID=775 | 20 Apr 2004
Inc. (NASDAQ:ABII), a fully integrated global biotechnology company dedicated
to the discovery, development and delivery of next-generation therapeutics and
http://www.azonano.com/news.aspx?newsID=11817 | 1 Jun 2009
Sorrento Therapeutics, Inc. (Sorrento) and IGDRASOL announced today that the companies will present Phase III interim data analysis of Cynviloq in metastatic breast cancer (MBC) patients showing...
http://www.azonano.com/news.aspx?newsID=27742 | 2 Jul 2013
Paclitaxel is a powerful anticancer agent used to treat a variety of malignancies,
but severe side effects limit its ultimate effectiveness and utility. To improve
http://www.azonano.com/news.aspx?newsID=7842 | 27 Sep 2008
University chemists have discovered a way to load dozens of
molecules of the anti-cancer drug paclitaxel onto tiny gold spheres.
The result is a tiny ball, many times smaller than a living...
http://www.azonano.com/news.aspx?newsID=4934 | 13 Sep 2007
Sorrento Therapeutics, Inc. (Sorrento), a late-stage clinical oncology company developing new treatments for cancer and associated pain, today announced that it will present results of preclinical...
http://www.azonano.com/news.aspx?newsID=29374 | 12 Feb 2014
Sorrento Therapeutics, Inc. announced today it will present the clinical data for Cynviloq™ (IG-001), which resulted in its approval as 1st line treatment of ovarian cancer by Korean FDA in...
http://www.azonano.com/news.aspx?newsID=28297 | 17 Sep 2013
Vascular Nanotransfer Technologies (“VNT”), an emerging medical technology company, announced today that large animal model in vivo tests of its paclitaxel nanocarrier-based Drug Coated Balloon...
http://www.azonano.com/news.aspx?newsID=25775 | 20 Oct 2012
By Cameron Chai
Decision Resources, a research and consultative firm for pharmaceutical and healthcare issues, offers analysis on the latest developments in the non-small-cell lung cancer drug...
http://www.azonano.com/news.aspx?newsID=24586 | 30 Mar 2012
When loaded with an anticancer drug, a delivery system based on a novel material
that its creators call a nanosponge is three to five times more effective at
reducing tumor growth than direct...
http://www.azonano.com/news.aspx?newsID=18587 | 16 Jul 2010